PRLog - Nov. 27, 2012 - CLEVELAND -- Dr. Michael Roizen, Chairman of the Wellness Institute at the Cleveland Clinic has joined Tersus Pharmaceuticals–
Provinal™ Purified Omega 7 (Palmitoleic Acid)
Tersus Pharmaceuticals has been conducting research & development with omega-7 palmitoleic acid, the next generation of Omega fatty acids that have been shown to possess broad properties to combat diabetes, metabolic syndrome, and atherosclerosis.
According to Dr. Roizen, this is exciting news because “Purified omega-7 at least in animals and in epidemiological studies, and some early intervention studies in man “antagonizes”
“With the development of Provinal™ and the other omega-7 palmitoleic acid products under development, Tersus Pharmaceuticals has placed itself squarely in the middle of the fight against diabetes, metabolic syndrome, and atherosclerosis. I’m very excited that this great work originated–and is being conducted–right here in Cleveland.”
“This could have a huge benefit for our populations as a whole because metabolic syndrome, insulin resistance, and diabetes are big things we need to tackle for us to be more competitive for jobs, and the United States to be more competitive as a society. We need more studies, but this could really be a great addition—that’
To see Dr. Roizen speaking about Atherosclerosis and Purified Omega 7, visit the Tersus Pharmaceuticals YouTube Channel at: https://www.youtube.com/
To learn more about the benefits of taking purified Omega 7 as a nutritional supplement, visit http://www.cardia7.com